Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Systemic Lupus Erythematosus
NCT07721324Phase 3Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in systemic lupus erythematosus (SLE), sponsored by Ain Shams University. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07721324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721324.